Eton Pharmaceuticals Inc (ETON)
US Market

Eton Pharmaceuticals Stock Analysis & Ratings



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Eton Pharmaceuticals’s price range in the past 12 months?
Eton Pharmaceuticals lowest stock price was $2.47 and its highest was $6.72 in the past 12 months.
    What is Eton Pharmaceuticals’s market cap?
    Currently, no data Available
    What is Eton Pharmaceuticals’s price target?
    The average price target for Eton Pharmaceuticals is $9.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 209.28% Increase from the current price of $2.91.
      What do analysts say about Eton Pharmaceuticals?
      Eton Pharmaceuticals’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
        When is Eton Pharmaceuticals’s upcoming earnings report date?
        Eton Pharmaceuticals’s upcoming earnings report date is Nov 17, 2022 which is in 96 days.
          How were Eton Pharmaceuticals’s earnings last quarter?
          Eton Pharmaceuticals released its earnings results on Aug 11, 2022. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.09.
            Is Eton Pharmaceuticals overvalued?
            According to Wall Street analysts Eton Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Eton Pharmaceuticals pay dividends?
              Eton Pharmaceuticals does not currently pay dividends.
              What is Eton Pharmaceuticals’s EPS estimate?
              Eton Pharmaceuticals’s EPS estimate is -$0.15.
                How many shares outstanding does Eton Pharmaceuticals have?
                Eton Pharmaceuticals has 25,224,451 shares outstanding.
                  What happened to Eton Pharmaceuticals’s price movement after its last earnings report?
                  Eton Pharmaceuticals reported an EPS of -$0.06 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went same N/A.
                    Which hedge fund is a major shareholder of Eton Pharmaceuticals?
                    Currently, no hedge funds are holding shares in ETON


                    Eton Pharmaceuticals Stock Analysis

                    Smart Score
                    Price Target
                    ▲(209.28% Upside)
                    Moderate Buy
                    The Eton Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Eton Pharmaceuticals Inc

                    Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines. The company was founded in April 2017 and is headquartered in Deer Park, IL.

                    Similar Stocks
                    Price & Change
                    Johnson & Johnson
                    Eli Lilly & Co
                    Merck & Company
                    Bristol Myers

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis